All Russian Regions Received the First Batches of “Sputnik V” Vaccine

29 September 2020

GMP News

All Russian regions have received first trial batches of the “Sputnik V” COVID-19 vaccine, developed for civilian circulation, the Russian Health Ministry’s press service informed reporters.

“All regions have received the first trial batches of the Gam-COVID-Vac vaccine (Sputnik V) for the prevention of the novel coronavirus infection developed by the N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology,” the message informs.

According to the federal information monitoring system, the vaccine is already being used in several Russian regions, with medical workers considered the priority. According to the system, there are over 27,000 marked packages of the vaccine so far. “Their number is increasing,” the press service informed.

Source

Print

Shareholders

Read more

Pipeline

Read more

Media Center

Read more